These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 18080858)

  • 1. Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.
    Borsetti A; Baroncelli S; Maggiorella MT; Bellino S; Moretti S; Sernicola L; Belli R; Ridolfi B; Farcomeni S; Negri DR; Cafaro A; Ensoli B; Titti F
    Arch Virol; 2008; 153(3):463-72. PubMed ID: 18080858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral burden and disease progression in rhesus monkeys infected with chimeric simian-human immunodeficiency viruses.
    Reimann KA; Watson A; Dailey PJ; Lin W; Lord CI; Steenbeke TD; Parker RA; Axthelm MK; Karlsson GB
    Virology; 1999 Mar; 256(1):15-21. PubMed ID: 10087222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P.
    Zhang ZQ; Schleif WA; Casimiro DR; Handt L; Chen M; Davies ME; Liang X; Fu TM; Tang A; Wilson KA; McElhaugh M; Carella A; Tan C; Connolly B; Hill S; Klein H; Emini EA; Shiver JW
    Virology; 2004 Mar; 320(1):75-84. PubMed ID: 15003864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus replication and disease progression inversely correlate with SIV tat evolution in morphine-dependent and SIV/SHIV-infected Indian rhesus macaques.
    Noel RJ; Kumar A
    Virology; 2006 Mar; 346(1):127-38. PubMed ID: 16313937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal transmission of pathogenic CXCR4-utilizing SHIVSF33A variants in rhesus macaques.
    Harouse JM; Tan RC; Gettie A; Dailey P; Marx PA; Luciw PA; Cheng-Mayer C
    Virology; 1998 Aug; 248(1):95-107. PubMed ID: 9705259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenicity of simian-human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses.
    Reimann KA; Parker RA; Seaman MS; Beaudry K; Beddall M; Peterson L; Williams KC; Veazey RS; Montefiori DC; Mascola JR; Nabel GJ; Letvin NL
    J Virol; 2005 Jul; 79(14):8878-85. PubMed ID: 15994781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor excision circles (TRECs) analysis during acute intrarectal infection of cynomolgus monkeys with pathogenic chimeric simian human immunodeficiency virus.
    Bona R; Macchia I; Baroncelli S; Negri DR; Leone P; Pavone-Cossut MR; Catone S; Buffa V; Ciccozzi M; Heeney J; Fagrouch Z; Titti F; Cara A
    Virus Res; 2007 Jun; 126(1-2):86-95. PubMed ID: 17336416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fusion of the upstream vpu sequences to the env of simian human immunodeficiency virus (SHIV(KU-1bMC33)) results in the synthesis of two envelope precursor proteins, increased numbers of virus particles associated with the cell surface and is pathogenic for pig-tailed macaques.
    Hout DR; Gomez ML; Pacyniak E; Mulcahy ER; Gomez LM; Jackson M; Flick M; Fegley B; McCormick C; Wisdom BJ; Culley N; Pinson DM; Powers M; Wong SW; Stephens EB
    Virology; 2004 May; 323(1):91-107. PubMed ID: 15165822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
    J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine.
    Cafaro A; Caputo A; Maggiorella MT; Baroncelli S; Fracasso C; Pace M; Borsetti A; Sernicola L; Negri DR; Ten Haaft P; Betti M; Michelini Z; Macchia I; Fanales-Belasio E; Belli R; Corrias F; Buttò S; Verani P; Titti F; Ensoli B
    J Med Primatol; 2000 Aug; 29(3-4):193-208. PubMed ID: 11085582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques.
    Kumar R; Orsoni S; Norman L; Verma AS; Tirado G; Giavedoni LD; Staprans S; Miller GM; Buch SJ; Kumar A
    Virology; 2006 Oct; 354(1):192-206. PubMed ID: 16876224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine.
    Cafaro A; Caputo A; Fracasso C; Maggiorella MT; Goletti D; Baroncelli S; Pace M; Sernicola L; Koanga-Mogtomo ML; Betti M; Borsetti A; Belli R; Akerblom L; Corrias F; Buttò S; Heeney J; Verani P; Titti F; Ensoli B
    Nat Med; 1999 Jun; 5(6):643-50. PubMed ID: 10371502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of less pathogenic infectious molecular clones derived from acute-pathogenic SHIV-89.6p stock virus.
    Kozyrev IL; Ibuki K; Shimada T; Kuwata T; Takemura T; Hayami M; Miura T
    Virology; 2001 Mar; 282(1):6-13. PubMed ID: 11259185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.
    Igarashi T; Imamichi H; Brown CR; Hirsch VM; Martin MA
    J Leukoc Biol; 2003 Nov; 74(5):772-80. PubMed ID: 14595005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simian immunodeficiency virus SIVmac239 infection and simian human immunodeficiency virus SHIV89.6P infection result in progression to AIDS in cynomolgus macaques of Asian origin.
    Okamura T; Tsujimura Y; Soma S; Takahashi I; Matsuo K; Yasutomi Y
    J Gen Virol; 2016 Dec; 97(12):3413-3426. PubMed ID: 27902330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular viral DNA detection and junction sequence analysis from PBMC of SHIV-infected cynomolgus monkeys with undetectable virus plasma RNA.
    Cara A; Maggiorella MT; Bona R; Sernicola L; Baroncelli S; Negri DR; Leone P; Fagrouch Z; Heeney J; Titti F; Cafaro A; Ensoli B
    Virology; 2004 Jul; 324(2):531-9. PubMed ID: 15207638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
    McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
    J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of pathogenic simian human immunodeficiency virus strains SHIV-89.6P and SHIV-KU2 in cynomolgus macaques.
    Pawar SN; Mattila JT; Sturgeon TJ; Lin PL; Narayan O; Montelaro RC; Flynn JL
    AIDS Res Hum Retroviruses; 2008 Apr; 24(4):643-54. PubMed ID: 18366326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Establishment of a real-time RT-PCR to detect plasma viral load of simian/human immunodeficiency virus CN97001 during its in vivo passage in rhesus monkeys].
    Liu Q; Li J; Yang GB; Xing H; Dai JJ; Shao YM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):174-6. PubMed ID: 17653328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Intact vpu and nef genes in nonpathogenic SHIV is essential for acquisition of pathogenicity of this virus by serial passage in macaques.
    Mackay GA; Niu Y; Liu ZQ; Mukherjee S; Li Z; Adany I; Buch S; Zhuge W; McClure HM; Narayan O; Smith MS
    Virology; 2002 Mar; 295(1):133-46. PubMed ID: 12033772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.